InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.004 -0.01 (-71.43%)+
Announcement
Release
30 Jan 2026 8:29AM
Price at Release
$0.014
Full Release
download
Summary
Enlitic, Inc., a medical technology software company specializing in AI-enabled healthcare solutions, reported its quarterly activities and cash flow for Q4 FY25. The company achieved a record total contract value of A$4.3m, reflecting continued growth in enterprise and OEM agreements, along with 16 new client agreements. Despite a lower quarterly revenue of US$0.8m due to expanded project scopes, Enlitic completed a capital raise of A$2.6m via convertible notes, with an additional tranche subject to approval. Operational cost discipline resulted in further cost savings and a strategic focus to achieve operational cash flow breakeven. Enlitic also reported a net operating cash outflow of US$3.3m for the quarter, with a cash balance of US$2.57m at the end of December 2025.
Key Points
  • Record total contract value of A$4.3m in Q4 FY25.
  • 16 new client agreements executed in Q4 FY25.
  • Completed capital raise of A$2.6m; additional A$5.4m subject to approval.
  • Net operating cash outflow of US$3.3m for the quarter.
  • Cash balance of US$2.57m at the end of December 2025.
  • Implemented cost reduction measures for US$2.5m in annual savings.
  • Revenue impacted by expanded project scopes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.